- Presentations
- 2
- Markets
- 2
Orserdu is a brand of Elacestrant marketed by Stemline Therapeutics, with 2 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Elacestrant
- Brand owner
- Stemline Therapeutics
- Registered in
- European Union, United States
- Strengths and forms
- 345 mg tablet, 86 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Orserdu 345 mg tabletOral | Stemline Therapeutics | US FDA | Available on request |
| Orserdu 86 mg tabletOral | Stemline Therapeutics | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Orserdu
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.